Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants
- PMID: 29422019
- PMCID: PMC5806251
- DOI: 10.1186/s12881-018-0535-7
Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants
Abstract
Background: Neuronal ceroid lipofuscinoses (NCLs) are one of the most frequent childhood-onset neurodegenerative pathologies characterized by seizures, progressive cognitive decline, motor impairment and loss of vision. For the past two decades, more than 430 variants in 13 candidate genes have been identified in the affected patients. Most of the variants were almost exclusively reported in Western patients, and very little clinical and genetic information was available for Chinese patients.
Case presentation: We report a Chinese boy whose clinical phenotypes were suspected to be NCL, including intractable epilepsy, cognitive and motor decline and progressive vision loss. Using targeted next-generation sequencing, two novel null variants in CLN8 (c.298C > T, p.Gln100Ter; c.551G > A, p.Trp184Ter) were detected in this patient in trans model. These two variants were interpreted as pathogenic according to the variant guidelines of the American College of Medical Genetics and Genomics.
Conclusions: This is the first case report of NCL due to CLN8 variants in China. Our findings expand the variant diversity of CLN8 and demonstrate the tremendous diagnosis value of targeted next-generation sequencing for pediatric NCLs.
Keywords: CLN8; Neuronal ceroid lipofuscinoses; Novel null variant.
Conflict of interest statement
Ethics approval and consent to participate
All research was approved by the ethics committee of Capital Institute of Pediatrics (SHERLL 2015069). The patient’s parents have provided written informed consent.
Consent for publication
The patient’s parents gave written informed consent to studies and publication of clinical information, images and sequencing data.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.Neuromolecular Med. 2019 Jun;21(2):160-169. doi: 10.1007/s12017-019-08529-7. Epub 2019 Mar 27. Neuromolecular Med. 2019. PMID: 30919163
-
A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: a case report.BMC Med Genet. 2018 Oct 1;19(1):177. doi: 10.1186/s12881-018-0690-x. BMC Med Genet. 2018. PMID: 30285654 Free PMC article.
-
A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.Mol Genet Metab. 2014 Aug;112(4):302-9. doi: 10.1016/j.ymgme.2014.05.014. Epub 2014 Jun 4. Mol Genet Metab. 2014. PMID: 24953404
-
Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.Mol Genet Metab. 2017 Mar;120(3):269-277. doi: 10.1016/j.ymgme.2016.12.007. Epub 2016 Dec 19. Mol Genet Metab. 2017. PMID: 28024876
-
Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.Hum Mutat. 2012 Jan;33(1):42-63. doi: 10.1002/humu.21624. Epub 2011 Nov 16. Hum Mutat. 2012. PMID: 21990111 Review.
Cited by
-
The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.Neuromolecular Med. 2019 Jun;21(2):160-169. doi: 10.1007/s12017-019-08529-7. Epub 2019 Mar 27. Neuromolecular Med. 2019. PMID: 30919163
-
High diagnostic yield of direct Sanger sequencing in the diagnosis of neuronal ceroid lipofuscinoses.JIMD Rep. 2019 Sep 3;50(1):20-30. doi: 10.1002/jmd2.12057. eCollection 2019 Nov. JIMD Rep. 2019. PMID: 31741823 Free PMC article.
-
Neuronal ceroid lipofuscinoses type 8: Expanding genotype/phenotype diversity-first report from Saudi Arabia.Neurosciences (Riyadh). 2020 Jan;25(1):65-69. doi: 10.17712/nsj.2020.1.20190103. Neurosciences (Riyadh). 2020. PMID: 31982899 Free PMC article.
-
Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis.J Neurol Sci. 2020 Jul 15;414:116826. doi: 10.1016/j.jns.2020.116826. Epub 2020 Apr 7. J Neurol Sci. 2020. PMID: 32302805 Free PMC article.
-
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.Mol Ther. 2021 Jan 6;29(1):162-175. doi: 10.1016/j.ymthe.2020.09.033. Epub 2020 Sep 24. Mol Ther. 2021. PMID: 33010819 Free PMC article.
References
-
- Wisniewski KE, Zhong N. Batten disease: diagnosis, treatment, and research. London: Adv Genet. Academic; 2001.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous